Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 4.70 is 30% above its 5-year average of 3.63, around the middle of its 5-year range (0.47–9.83).
As of the fiscal period ended Tuesday, June 30, 2026. 30.09% below its 12-month average of 6.73.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.70.
QUICK RATIO (ACID-TEST)
4.70
QUICK RATIO (ACID-TEST) AVG TTM
6.73
QUICK RATIO (ACID-TEST) AVG 3Y
4.95
QUICK RATIO (ACID-TEST) AVG 5Y
3.63
QUICK RATIO (ACID-TEST) AVG 10Y
2.67
QUICK RATIO (ACID-TEST) AVG 15Y
2.33
QUICK RATIO (ACID-TEST) AVG 20Y
1.63
CURRENT VS TTM AVG
-30.09%
CURRENT VS 3Y AVG
-4.98%
CURRENT VS 5Y AVG
+29.54%
CURRENT VS 10Y AVG
+75.88%
CURRENT VS 15Y AVG
+102.11%
CURRENT VS 20Y AVG
+188.01%
SECTOR MEDIAN · HEALTHCARE
2.94
median of 513 covered companies
CURRENT VS SECTOR MEDIAN
+59.97%
vs the sector median at left
CAMP4 Therapeutics Corporation
Market Cap
$252.90M
Quick Ratio (Acid-Test)
4.70
TTM Avg
6.73
3Y Avg
4.95
5Y Avg
3.63
Market Cap
$251.06M
Quick Ratio (Acid-Test)
5.86
TTM Avg
4.06
3Y Avg
6.91
5Y Avg
7.76
Market Cap
$249.82M
Quick Ratio (Acid-Test)
1.54
TTM Avg
1.17
3Y Avg
19.33
5Y Avg
29.22
Market Cap
$246.96M
Quick Ratio (Acid-Test)
0.10
TTM Avg
1.46
3Y Avg
1.56
5Y Avg
2.73
Market Cap
$260.11M
Quick Ratio (Acid-Test)
15.82
TTM Avg
24.04
3Y Avg
14.70
5Y Avg
12.06
Market Cap
$261.48M
Quick Ratio (Acid-Test)
16.00
TTM Avg
13.11
3Y Avg
8.33
5Y Avg
7.81
Market Cap
$244.19M
Quick Ratio (Acid-Test)
2.69
TTM Avg
2.01
3Y Avg
1.61
5Y Avg
1.29
Market Cap
$242.46M
Quick Ratio (Acid-Test)
17.19
TTM Avg
13.55
3Y Avg
8.08
5Y Avg
8.08
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CAMP4 Therapeutics Corporation (CAMP) | $252.90M | 4.70 | 6.73 | 4.95 | 3.63 |
| Invivyd, Inc. (IVVD)vs › | $251.06M | 5.86 | 4.06 | 6.91 | 7.76 |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $249.82M | 1.54 | 1.17 | 19.33 | 29.22 |
| InflaRx N.V. (IFRX)vs › | $248.92M | 8.22 | 4.35 | 5.50 | 5.94 |
| Galectin Therapeutics Inc. (GALT)vs › | $246.96M | 0.10 | 1.46 | 1.56 | 2.73 |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $260.11M | 15.82 | 24.04 | 14.70 | 12.06 |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $261.48M | 16.00 | 13.11 | 8.33 | 7.81 |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.19M | 2.69 | 2.01 | 1.61 | 1.29 |
| BioAge Labs Inc. (BIOA)vs › | $242.46M | 17.19 | 13.55 | 8.08 | 8.08 |
| Anika Therapeutics, Inc. (ANIK)vs › | $264.05M | 3.19 | 3.85 | 4.21 | 4.14 |
Quick Ratio
4.70
Excludes inventory
Current Ratio
4.70
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 4.70 |
| 2026-03-31 | 6.15 |
| 2025-12-31 | 7.35 |
| 2025-09-30 | 9.83 |
| 2025-06-30 | 5.60 |
| 2025-03-31 | 8.02 |
| 2024-12-31 | 6.92 |
| 2024-09-30 | 0.47 |
| 2024-06-30 | 1.90 |
| 2024-03-31 | 1.90 |
| 2023-12-31 | 5.13 |
| 2023-08-31 | 1.43 |
| 2023-05-31 | 1.45 |
| 2023-02-28 | 1.42 |
| 2022-11-30 | 1.47 |
| 2022-08-31 | 1.62 |
| 2022-05-31 | 1.74 |
| 2022-02-28 | 1.80 |
| 2021-11-30 | 1.83 |
| 2021-08-31 | 1.89 |
| 2021-05-31 | 1.93 |
| 2021-02-28 | 1.78 |
| 2020-11-30 | 1.70 |
| 2020-08-31 | 1.94 |
| 2020-05-31 | 1.96 |
| 2020-02-29 | 1.66 |
| 2019-11-30 | 1.61 |
| 2019-08-31 | 1.36 |
| 2019-05-31 | 1.40 |
| 2019-02-28 | 4.44 |
| 2018-11-30 | 3.96 |
| 2018-08-31 | 4.07 |
| 2018-05-31 | 2.59 |
| 2018-02-28 | 2.51 |
| 2017-11-30 | 2.36 |
| 2017-08-31 | 2.36 |
| 2017-05-31 | 2.17 |
| 2017-02-28 | 2.32 |
| 2016-11-30 | 2.37 |
| 2016-08-31 | 2.35 |
| 2016-05-31 | 2.35 |
| 2016-02-29 | 5.69 |
| 2015-11-30 | 6.10 |
| 2015-08-31 | 4.96 |
| 2015-05-31 | 5.37 |
| 2015-02-28 | 2.31 |
| 2014-11-30 | 1.86 |
| 2014-08-31 | 1.82 |
| 2014-05-31 | 2.08 |
| 2014-02-28 | 1.83 |
| 2013-11-30 | 2.13 |
| 2013-08-31 | 1.84 |
| 2013-05-31 | 1.88 |
| 2013-02-28 | 3.22 |
| 2012-11-30 | 1.54 |
| 2012-08-31 | 1.38 |
| 2012-05-31 | 1.12 |
| 2012-02-28 | 1.26 |
| 2011-11-26 | 0.93 |
| 2011-08-27 | 0.87 |
| 2011-05-28 | 0.91 |
| 2011-02-28 | 0.86 |
| 2010-11-27 | 0.00 |
| 2010-08-28 | 0.73 |
| 2010-05-29 | 0.73 |
| 2010-02-28 | 0.81 |
| 2009-11-28 | 0.64 |
| 2009-08-29 | 0.58 |
| 2009-05-30 | 0.59 |
| 2009-02-28 | 0.64 |
| 2008-11-29 | 0.57 |
| 2008-08-30 | 0.58 |
| 2008-05-31 | 1.01 |
| 2008-03-01 | 1.04 |
| 2007-12-01 | 0.67 |
| 2007-09-01 | 0.61 |
| 2007-06-02 | 0.61 |
| 2007-03-03 | 2.27 |
| 2006-11-30 | 3.08 |
| 2006-08-31 | 2.70 |
| 2006-05-31 | 2.08 |
| 2006-02-28 | 3.70 |
| 2005-11-30 | 2.81 |
| 2005-08-31 | 2.65 |
| 2005-05-31 | 1.99 |
| 2005-02-28 | 2.26 |
| 2004-11-30 | 1.68 |
| 2004-08-31 | 1.43 |
| 2004-05-31 | 1.58 |
| 2004-02-28 | 1.92 |
| 2003-11-30 | 2.11 |
| 2003-08-31 | 2.42 |
| 2003-05-31 | 2.84 |
| 2003-03-01 | 2.19 |
| 2002-11-30 | 2.61 |
| 2002-08-31 | 3.21 |
